Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Alternative Investment Management Association (AIMA) is the global representative for the alternative investment industry, encompassing hedge funds, private credit, and other non-traditional asset classes. Founded in 1990, the organization serves as a central hub for advocacy, policy development, and the establishment of industry-wide best practices. AIMA represents over 2,100 corporate members across more than 60 countries, including fund managers, institutional investors, and professional service providers. Its primary mission is to promote the industry's value to the global economy and ensure a sustainable regulatory environment. While AIMA provides educational resources and networking opportunities, it does not engage in life sciences research or healthcare product development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alternative Investment Management Association.